HSE approves Patisiran for amyloidosis patients
Donegal Action for Cancer Care has been told that the drug Patisiran will be made available to patients with amyloidosis, a condition that is particularly prevalent in the North West. After raising the issue in online meeting with the HSE and Health Minister Stephen Donnelly, DACC were advised by Chief Clinical Officer Colm Henry at […]
HSE approves Patisiran for amyloidosis patients Read More »














































